Daclizumab Subcutaneous and Infections
Result of checking the interaction of drug Daclizumab Subcutaneous and disease Infections for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Infections of the upper respiratory tract, urinary tract, and viral infections, sometimes serious, have been reported with the use of daclizumab. It is recommended to avoid daclizumab in patients with a severe active infection. Monitor for signs and symptoms of an infection and consider withholding treatment until the infection resolves.
Generic Name: daclizumab
Brand Name: Zinbryta, Zenapax
Synonyms: Daclizumab
Daclizumab Subcutaneous - infekcje 
Daclizumab Subcutaneous - infecções 
Daclizumab Subcutaneous - jangkitan 
Daclizumab Subcutaneous - infeksi 
Daclizumab Subcutaneous - infezioni 
Daclizumab Subcutaneous - infections 
Daclizumab Subcutaneous - Infektionen 
Daclizumab Subcutaneous - infecciones 
Daclizumab Subcutaneous - инфекции 
Daclizumab Subcutaneous - enfeksiyonlar 
Daclizumab Subcutaneous - الالتهابات 
Daclizumab Subcutaneous - 感染